These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33372514)

  • 1. Dual-Responsive and Deep-Penetrating Nanomicelles for Tumor Therapy via Extracellular Matrix Degradation and Oxidative Stress.
    Wang Z; Xu Y; Wu G; Zuo T; Zhang J; Yang J; Yang Y; Fang T; Shen Q
    ACS Biomater Sci Eng; 2021 Jan; 7(1):166-179. PubMed ID: 33372514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy.
    Li J; Wang Y; Xu C; Yu Q; Wang X; Xie H; Tian L; Qiu Y; Guo R; Lu Z; Li M; He Q
    Acta Biomater; 2021 Oct; 134():546-558. PubMed ID: 33882357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
    Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
    Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
    Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism Investigation of Hyaluronidase-Combined Multistage Nanoparticles for Solid Tumor Penetration and Antitumor Effect.
    Chen E; Han S; Song B; Xu L; Yuan H; Liang M; Sun Y
    Int J Nanomedicine; 2020; 15():6311-6324. PubMed ID: 32922003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Sequential Target-Responsive Nanocarrier with Enhanced Tumor Penetration and Neighboring Effect In Vivo.
    Cui T; Yan Z; Qin H; Sun Y; Ren J; Qu X
    Small; 2019 Oct; 15(42):e1903323. PubMed ID: 31468717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detachable Dual-Targeting Nanoparticles for Improving the Antitumor Effect by Extracellular Matrix Depletion.
    Duan S; Sun F; Qiao P; Zhu Z; Geng M; Gong X; Li Y; Yao H
    ACS Biomater Sci Eng; 2023 Mar; 9(3):1437-1449. PubMed ID: 36795746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction and Anti-tumor Effect Evaluation of a Dual-Responsive Hyaluronic Acid Carbon Quantum Dot-Gelatin Nano-Drug Delivery System].
    Li M; Li JP; Wang YS; He Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):577-584. PubMed ID: 34323034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TME-Responsive Polyprodrug Micelles for Multistage Delivery of Doxorubicin with Improved Cancer Therapeutic Efficacy in Rodents.
    Zhang S; Zhu P; He J; Dong S; Li P; Zhang CY; Ma T
    Adv Healthc Mater; 2020 Sep; 9(18):e2000387. PubMed ID: 32815646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a tumor microenvironment pH-responsive cleavable PEGylated hyaluronic acid nano-drug delivery system for colorectal cancer treatment.
    Zhang X; Zhao M; Cao N; Qin W; Zhao M; Wu J; Lin D
    Biomater Sci; 2020 Mar; 8(7):1885-1896. PubMed ID: 32022813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction Responsive Self-Assembled Nanoparticles Based on Disulfide-Linked Drug-Drug Conjugate with High Drug Loading and Antitumor Efficacy.
    Song Q; Wang X; Wang Y; Liang Y; Zhou Y; Song X; He B; Zhang H; Dai W; Wang X; Zhang Q
    Mol Pharm; 2016 Jan; 13(1):190-201. PubMed ID: 26629710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor microenvironment dual-responsive core-shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNA.
    Wang T; Yu X; Han L; Liu T; Liu Y; Zhang N
    Int J Nanomedicine; 2017; 12():4773-4788. PubMed ID: 28740384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational Design of Nanoparticles to Overcome Poor Tumor Penetration and Hypoxia-Induced Chemotherapy Resistance: Combination of Optimizing Size and Self-Inducing High Level of Reactive Oxygen Species.
    Deng L; Feng Z; Deng H; Jiang Y; Song K; Shi Y; Liu S; Zhang J; Bai S; Qin Z; Dong A
    ACS Appl Mater Interfaces; 2019 Sep; 11(35):31743-31754. PubMed ID: 31389686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemo-Photothermal Combination Cancer Therapy with ROS Scavenging, Extracellular Matrix Depletion, and Tumor Immune Activation by Telmisartan and Diselenide-Paclitaxel Prodrug Loaded Nanoparticles.
    Fang T; Zhang J; Zuo T; Wu G; Xu Y; Yang Y; Yang J; Shen Q
    ACS Appl Mater Interfaces; 2020 Jul; 12(28):31292-31308. PubMed ID: 32551473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery.
    Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A
    Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hierarchically Releasing Bio-Responsive Nanoparticles for Complete Tumor Microenvironment Modulation via TGF-β Pathway Inhibition and TAF Reduction.
    Zhang J; Zuo T; Yang J; Hu Z; Wang Z; Xu R; Ma S; Wei Y; Shen Q
    ACS Appl Mater Interfaces; 2021 Jan; 13(2):2256-2268. PubMed ID: 33423468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
    Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
    Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulfate targeting strategy for enhancing liposomal drug accumulation and facilitating deep distribution in tumors.
    Kuo PH; Teng YH; Cin AL; Han W; Huang PW; Wang LH; Chou YT; Yang JL; Tseng YL; Kao M; Chang MD
    Drug Deliv; 2020 Dec; 27(1):542-555. PubMed ID: 32241176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
    Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
    Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.